The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Fulcrum Therapeutics Inc’s stock clocked out at $6.88, down -3.10% from its previous closing price of $7.1. In other words, the price has decreased by -$3.10 from its previous closing price. On the day, 1.02 million shares were traded. FULC stock price reached its highest trading level at $7.27 during the session, while it also had its lowest trading level at $6.87.
Ratios:
To gain a deeper understanding of FULC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.12. For the most recent quarter (mrq), Quick Ratio is recorded 28.71 and its Current Ratio is at 28.71. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On May 15, 2025, Cantor Fitzgerald Upgraded its rating to Overweight which previously was Neutral but kept the price unchanged to $10.
H.C. Wainwright Downgraded its Buy to Neutral on September 13, 2024, whereas the target price for the stock was revised from $17 to $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 08 ’25 when Tourangeau Greg sold 498 shares for $5.06 per share. The transaction valued at 2,520 led to the insider holds 14,062 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FULC now has a Market Capitalization of 371377600 and an Enterprise Value of 152879632. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.64 while its Price-to-Book (P/B) ratio in mrq is 1.63. Its current Enterprise Value per Revenue stands at 1.911 whereas that against EBITDA is -17.108.
Stock Price History:
The Beta on a monthly basis for FULC is 2.39, which has changed by 0.12786889 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, FULC has reached a high of $10.13, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is 15.29%, while the 200-Day Moving Average is calculated to be 63.48%.
Shares Statistics:
It appears that FULC traded 573.15K shares on average per day over the past three months and 679280 shares per day over the past ten days. A total of 53.98M shares are outstanding, with a floating share count of 47.85M. Insiders hold about 11.36% of the company’s shares, while institutions hold 85.60% stake in the company. Shares short for FULC as of 1749772800 were 5820117 with a Short Ratio of 10.15, compared to 1747267200 on 4928661. Therefore, it implies a Short% of Shares Outstanding of 5820117 and a Short% of Float of 15.58.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
